| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| M0244 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency |
169 |
168 |
$111K |
| M0246 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider based to the hospital during the covid 19 public health emergency |
89 |
89 |
$65K |
| M0223 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency |
155 |
153 |
$56K |
| M0248 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency |
43 |
43 |
$27K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
413 |
401 |
$10K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
231 |
229 |
$7K |
| 99442 |
|
337 |
333 |
$6K |
| 99306 |
Prolong nursin fac eval 15m |
149 |
149 |
$6K |
| 99424 |
|
58 |
58 |
$2K |
| 99305 |
|
13 |
13 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
12 |
12 |
$277.24 |
| 36410 |
|
32 |
31 |
$216.24 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
351 |
341 |
$211.42 |
| 99457 |
|
27 |
27 |
$21.97 |
| 99458 |
|
33 |
26 |
$21.97 |